InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: petemantx post# 331698

Friday, 11/06/2020 6:27:38 AM

Friday, November 06, 2020 6:27:38 AM

Post# of 403568
Good things are happening at IPIX! Great post.

Go Leo & IPIX!

The pre-peer review article, which has already been or will soon be, sent out to all the world's leading virology experts IS the empirical data per testing at a government sponsored lab that the world of medicine was waiting to see.

It is the document that takes Brilacidin from speculation among those that may have only heard of Brilacidin to actually seeing data so that they can compare Brilacidin to ALL current virus treatments and show them that it's uses should extend far, far beyond any other drug out there due to it's three properties of being antibacterial, antiviral, and having immuno/anti-inflammatory properties.

This is not a fringe drug the virologists are learning about, they will recognize that it is the swiss army-knife equivalent to solve the problems of their field.

We do need the human trial results to give proof of the ability of B to work as well in humans as in vitro and in vero test indicate as evidenced by the SI of 426. This will allow massive funds to be directed to further B testing and start BPs offering deals as to partnering for specific indications. Also the requirement for share price to actually start rising and not retreating a matter of days later.

The cat is out of the bag regarding Brilacidin in the area of its anti-viral properties and possible indications across the entire coronavirus spectrum.

The ABSSSI already showed its strength of being a great antibiotic.
The pulmonary results from the CV trial in being able to clear up severe lung problems should make it a star in the pulmonary field and other areas where an effective and safe anti-inflammatory is needed.

But we need publicity beyond just the medical world and I think that ball of wax gets taken care of as early as next week. Important people in politics and the media know about Brilacidin, I think the reins they have had put on them have been removed and they will make Brilacidin known to the general public in a big way very, very soon!!


Brilacidin In a human lung cell line infected by SARS-CoV-2, Brilacidin achieved a high Selectivity Index rating of 426.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News